An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Lisdexamfetamine Dimesylate Tablet, Chewable
Status: Currently in Shortage
»Date first posted: 07/14/2023
»Therapeutic Categories: Psychiatry

Sun Pharmaceutical Industries, Inc. (Revised 03/15/2024)

Company Contact Information:
800-818-4555

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Tablet, Chewable, 10 mg (NDC 57664-083-88)	Unavailable	Not available. Return to stock possible in end of March 2024	Shortage of an active ingredient
Tablet, Chewable, 20 mg (NDC 57664-084-88)	Unavailable	Not available. Return to stock possible in end of March 2024	Shortage of an active ingredient
Tablet, Chewable, 30 mg (NDC 57664-085-88)	Unavailable	Not available. Return to stock possible in end of March 2024	Shortage of an active ingredient
Tablet, Chewable, 50 mg (NDC 57664-087-88)	Unavailable	Not available. Return to stock possible in end of March 2024	Shortage of an active ingredient
Tablet, Chewable, 60 mg (NDC 57664-088-88)	Unavailable	Not available. Return to stock possible in end of March 2024	Shortage of an active ingredient
Tablet, Chewable, 40 mg (NDC 57664-086-88)	Unavailable	Not available. Return to stock possible in end of March 2024	Shortage of an active ingredient

Takeda Pharmaceuticals USA Inc. (Reverified 04/15/2024)

Company Contact Information:
877-TAKEDA-7 (1-877-825-3327)

Presentation	Availability and Estimated Shortage Duration	Related Information	Shortage Reason (per FDASIA)
Vyvanse, Tablet, Chewable, 10 mg (NDC 59417-115-01)	Available
Vyvanse, Tablet, Chewable, 20 mg (NDC 59417-116-01)	Available
Vyvanse, Tablet, Chewable, 30 mg (NDC 59417-117-01)	Available
Vyvanse, Tablet, Chewable, 40 mg (NDC 59417-118-01)	Available
Vyvanse, Tablet, Chewable, 50 mg (NDC 59417-119-01)	Available
Vyvanse, Tablet, Chewable, 60 mg (NDC 59417-120-01)	Available

Top